ImmunityBio, Inc. — Director's Dealing 2016

May 26, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NantKwest, Inc. (NK)
CIK: 0001326110
Period of Report: 2016-05-23

Reporting Person: GORLIN STEVE (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-05-23	Common Stock	M	324012	$0.2161	Acquired	729725	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-05-23	Stock Option (right to buy)	$0.2161	M	324012	Disposed	2024-03-17	Common Stock (324012)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	221720	Indirect